Aligos Therapeutics, Inc. (ALGS)
6.965
-0.06
(-0.92%)
USD |
NASDAQ |
Mar 02, 16:00
7.025
+0.06
(+0.86%)
After-Hours: 20:00
Aligos Therapeutics Cash from Investing (TTM) : -15.83M for Sept. 30, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Johnson & Johnson | -23.59B |
| ACADIA Pharmaceuticals, Inc. | -302.56M |
| Agenus, Inc. | 0.393M |
| Alnylam Pharmaceuticals, Inc. | 436.33M |
| Savara, Inc. | 93.02M |